Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03038568 · ClinicalTrials.gov registry record
Assessing How Normal Variations in CT Scanning Affects Its Interpretation
A clinical trial of Colorectal Cancer Metastatic, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 169
- Enrollment target
- 2
- Study locations
NCT03038568: Active study of Colorectal Cancer Metastatic, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03038568 is a study of Colorectal Cancer Metastatic that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 169 participants, below the 196-participant average among 18 other Colorectal Cancer Metastatic trials with a reported enrollment target (14% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03038568, a study of Colorectal Cancer Metastatic, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 169 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to see how measurements of tumor differences vary with slight changes in CT scan parameters. Reproducible radiomic features can be extracted for abdominal tumors, and specifically colorectal liver metastases, imaged with clinical CT scanners even in the setting of variable scan parameters and variable contrast timing. Participants will be consented to undergo an additional CT of their abdomen.
Primary Outcome
There will be 18 cohorts, each cohort differing by the length of the time gap in acquisition and noise index. In addition each acquisition will be reconstructed in 21 different ways (combinations of 3 slice thicknesses and 7 ASiR levels).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CT scan
Study Locations (2)
New York
- Memorial Sloan Kettering Cancer Center - New York
Texas
- MD Anderson Cancer Center, Texas (Data collection only) - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2017-01-27 |
| Est. Completion | 2026-01-27 |
What the registry record for NCT03038568 still lists
NCT03038568 is an observational study that tracks outcomes without assigning an intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 196-participant average among 18 other Colorectal Cancer Metastatic trials with a reported enrollment target (14% lower).
The record links to 1 condition, with Colorectal Cancer Metastatic appearing as the primary indexed condition, and to 1 intervention - of which CT scan is the first listed.
NCT03038568 reports a single indexed study location in New York, Texas.
Frequently Asked Questions
What is clinical trial NCT03038568 about?
NCT03038568 is a clinical study titled "Assessing How Normal Variations in CT Scanning Affects Its Interpretation". The purpose of the study is to see how measurements of tumor differences vary with slight changes in CT scan parameters. Reproducible radiomic features can be extracted for abdominal tumors, and specifically colorectal liver metastases, imaged with clinical CT scanners even in the setting of variabl...
What is the current status of trial NCT03038568?
This trial is currently active not recruiting. The enrollment target is 169 participants. The study started on 2017-01-27. Estimated completion is 2026-01-27.
What conditions does trial NCT03038568 study?
This clinical trial studies the following conditions: Colorectal Cancer Metastatic.
What interventions are being tested in trial NCT03038568?
The interventions under investigation include: CT scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03038568?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03038568 being conducted?
This trial has 2 study locations across New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Metastatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03038568's enrollment target sits among peer trials
169 3rd of 18 higher than 16 of 18 other Colorectal Cancer Metastatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Metastatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
RECRUITING · Phase 2
-
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
RECRUITING
-
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
RECRUITING · Early Phase 1
-
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
RECRUITING
-
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
RECRUITING · Early Phase 1
-
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI